- Clinical Impact of Pathology Reviews of Outside Material: A Patient-Focused Approach
[作者:Banerjee, D; Gascoyne, RD; Slack, G; Hayes, M; Sehn, LH; Connors, JM,期刊:Journal of clinical oncology, 页码:4212-4213 , 文章类型: Letter,,卷期:2011年29-31]
-
- Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma
[作者:Polley, MYC; Lamborn, KR; Chang, SM; Butowski, N; Clarke, JL; Prados, M,期刊:Journal of clinical oncology, 页码:4175-4180 , 文章类型: Article,,卷期:2011年29-31]
- Purpose The disease outcome for patients with cancer is typically described in terms of estimated survival from diagnosis. Conditional probability offers more relevant information regarding survival for patients once the...
- Determining True HER2 Gene Status in Breast Cancers With Polysomy by Using Alternative Chromosome 17 Reference Genes: Implications for Anti-HER2 Targeted Therapy
[作者:Tse, CH; Hwang, HC; Goldstein, LC; Kandalaft, PL; Wiley, JC; Kussick, SJ; Gown, AM,期刊:Journal of clinical oncology, 页码:4168-4174 , 文章类型: Article,,卷期:2011年29-31]
- Purpose The ratio of human epidermal growth factor receptor 2 (HER2) to CEP17 by fluorescent in situ hybridization (FISH) with the centromeric probe CEP17 is used to determine HER2 gene status in breast cancer. Increases...
- DNA Repair Capacity in Peripheral Lymphocytes Predicts Survival of Patients With Non-Small-Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy
[作者:Wang, LE; Yin, M; Dong, Q; Stewart, DJ; Merriman, KW; Amos, CI; Spitz, MR; Wei, QY,期刊:Journal of clinical oncology, 页码:4121-4128 , 文章类型: Article,,卷期:2011年29-31]
- Purpose Platinum-based regimens are the standard chemotherapy for patients with advanced non-small-cell lung cancer (NSCLC). DNA repair capacity (DRC) in tumor cells plays an important role in resistance to platinum-base...
- Alternative End Points to Evaluate a Therapeutic Strategy in Advanced Colorectal Cancer: Evaluation of Progression-Free Survival, Duration of Disease Control, and Time to Failure of Strategy-An Aide et Recherche en Cancerologie Digestive Group Study
[作者:Chibaudel, B; Bonnetain, F; Shi, Q; Buyse, M; Tournigand, C; Sargent, DJ; Allegra, CJ; Goldberg, RM; de Gramont, A,期刊:Journal of clinical oncology, 页码:4199-4204 , 文章类型: Article,,卷期:2011年29-31]
- Purpose Progression-free survival (PFS) is not an optimal end point to evaluate therapeutic strategies in advanced colorectal cancer (ACRC). Therefore, composite end points have been proposed to evaluate a chemotherapy s...
- Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
[作者:Basch, E; Prestrud, AA; Hesketh, PJ; Kris, MG; Feyer, PC; Somerfield, MR; Chesney, M; Clark-Snow, RA; Flaherty, AM; Freundlich, B; Morrow, G; Rao, KV; Schwartz, RN; Lyman, GH,期刊:Journal of clinical oncology, 页码:4189-4198 , 文章类型: Article,,卷期:2011年29-31]
- Purpose To update the American Society of Clinical Oncology (ASCO) guideline for antiemetics in oncology. Methods A systematic review of the medical literature was completed to inform this update. MEDLINE, the Cochrane C...
- Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
[作者:Loehrer, PJ; Feng, Y; Cardenes, H; Wagner, L; Brell, JM; Cella, D; Flynn, P; Ramanathan, RK; Crane, CH; Alberts, SR; Benson, A,期刊:Journal of clinical oncology, 页码:4105-4112 , 文章类型: Article,,卷期:2011年29-31]
- Purpose The purpose of this trial was to evaluate the role of radiation therapy with concurrent gemcitabine (GEM) compared with GEM alone in patients with localized unresectable pancreatic cancer. Patients and Methods Pa...
- Randomized, Double-Blind, Placebo-Controlled Phase II Study of Single-Agent Oral Talactoferrin in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer That Progressed After Chemotherapy
[作者:Parikh, PM; Vaid, A; Advani, SH; Digumarti, R; Madhavan, J; Nag, S; Bapna, A; Sekhon, JS; Patil, S; Ismail, PM; Wang, YY; Varadhachary, A; Zhu, JM; Malik, R,期刊:Journal of clinical oncology, 页码:4129-4136 , 文章类型: Article,,卷期:2011年29-31]
- Purpose To investigate the activity and safety of oral talactoferrin (TLF) in patients with stages IIIB to IV non-small-cell lung cancer (NSCLC) for whom one or two prior lines of systemic anticancer therapy had failed. ...
- Health Care Use of Long-Term Survivors of Childhood Cancer: The British Childhood Cancer Survivor Study
[作者:Rebholz, CE; Reulen, RC; Toogood, AA; Frobisher, C; Lancashire, ER; Winter, DL; Kuehni, CE; Hawkins, MM,期刊:Journal of clinical oncology, 页码:4181-4188 , 文章类型: Article,,卷期:2011年29-31]
- Purpose Survivors of childhood cancer are at high risk of chronic conditions, but few studies investigated whether this translates into increased health care utilization. We compared health care service utilization betwe...
- Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort Study
[作者:Swerdlow, AJ; Higgins, CD; Smith, P; Cunningham, D; Hancock, BW; Horwich, A; Hoskin, PJ; Lister, TA; Radford, JA; Rohatiner, AZS; Linch, DC,期刊:Journal of clinical oncology, 页码:4096-4104 , 文章类型: Article,,卷期:2011年29-31]
- Purpose We investigated the long-term risk of second primary malignancy after chemotherapy for Hodgkin's lymphoma (HL) in a much larger cohort than any yet published, to our knowledge. Patients and Methods We followed 5,...
- Stereotactic Brachytherapy With Iodine-125 Seeds for the Treatment of Inoperable Low-Grade Gliomas in Children: Long-Term Outcome
[作者:Ruge, MI; Simon, T; Suchorska, B; Lehrke, R; Hamisch, C; Koerber, F; Maarouf, M; Treuer, H; Berthold, F; Sturm, V; Voges, J,期刊:Journal of clinical oncology, 页码:4151-4159 , 文章类型: Article,,卷期:2011年29-31]
- Purpose Resection is generally considered the gold standard for treatment of low-grade (WHO grades I and II) gliomas (LGGs) in childhood. However, approximately 30% to 50% of these tumors are inoperable because of their ...
|